Market Trends: Predicting the Global Genomics and Proteomics Instrument Market

Genomics and Proteomics Instrument Market

Genomics and Proteomics Instrument Market

A global research firm—Technavio released a latest report, saying that in 2013-2018, it is expected that the global genomics and proteomics analysis equipment market will maintain a Compound Annual Growth Rate (CAGR) of 7.83%.

Genomics is the discipline that studies genes and their functions; proteomics researches the structural and functional features of proteins or histones; both are based on molecular biology and bioinformatics tools and techniques.

Genomics is understood by figuring a gene and its DNA sequence to know the structure and function of the genome. A group of proteins is a set of proteins expressed in the genome within a specific time. Proteomics is mainly related to the use of molecular biology, biochemistry and genetics to analyze the proteins that are encoded by genes.

Protein is a major component of all cells, controlling different functional properties of cells. Structural or functional defects of genome or proteome could lead to diseases, so the genomics and proteomics technology plays an important role in scientific research, drug discovery, and disease diagnosis. These applications require the identification and study of proteins and gene defects, and those genomic and proteomic protein studies involve separation, purification, identification, quantification and analysis, which require instruments, reagents and software etc.

Instruments, for example, used in genomics and proteomics include the chromatographic system, MS system, PCR systems, and next-generation sequencing systems.

Currently, the main suppliers devoted to the field of genomics and proteomics have Agilent, Bio-Rad, Roche, Illumina, PE, Thermo, GE Healthcare, CD Genomics, JASCO, Japan Electronics, Creative Proteomcis, Luminex, Sigma, Spectrolab Systems, and Waters and so on.

The main driving force for the development of genomics and proteomics lies in the improvement of technologies, while the main challenge is the lack of knowledge. The main trend focuses on drug development and disease diagnosis.